Balls Noguera et al. Intensive Care Medicine Experimental 2015, 3(Suppl 1):A114 http://www.icm-experimental.com/content/3/S1/A114
POSTER PRESENTATION Open Access
Predictors of in-hospital mortality in critically ill patients with secondary and tertiary peritonitis
J Balls Noguera, V Corral-Velez*, JC Lopez-Delgado, NL Betancur-Zambrano, M Rojas-Lora, N Lopez-Sue,
XL Perez Fernandez, J Sabater Riera From ESICM LIVES 2015
Berlin, Germany. 3-7 October 2015
Introduction
Critically ill surgical patients remain at high risk of adverse outcomes as a result of intra-abdominal infection and its related prolonged length ICU of stay.
Objectives
The aim of our study was to identify the risk factors for in-hospital mortality of ICU patients suffering from complicated peritonitis, together with those factors associated with the development of tertiary peritonitis.
Methods
Prospective, observational study at our institution from 2011 to 2013. Baseline characteristics on admission, outcomes, microbiological results and antibiotics were used in our database for analysis.
Results
343 patients were included, 158 (46.1%) with secondary and 185 (53.9%) with tertiary peritonitis. 64.4% were male, age was 63.7 14.3 years and APACHE was 19.4 7.8. In-hospital mortality was 37%. We showed a higher incidence of Candida spp. (Odds Ratio(OR):1.275;95% Confidence Interval(CI):1.096-1.789;P=0.016), Enterococcus faecium (OR:1.085;95% CI:1.018-1.400;P=0.002) and Enterococcus spp. (OR:1.370;95% CI:1.139-1.989; P=0.047) in tertiary peritonitis. Higher rates in the use of cephalosporins was shown in secondary peritonitis (OR:3.51;95% CI:1.139-10.817;P=0.035). Longer ICU stay (OR:1.019;95% CI:1.004-1.034;P = 0.010), urgent surgery (OR:3.247;95% CI:1.392-7.575;P = 0.006), total parenteral nutrition (OR:3.079;95% CI:1.535-6.177; P = 0.002) and stomach-duodenum as primary infection
site (OR:4.818;95% CI:1.429-16.247; P = 0.011) were factors associated with the development of tertiary peritonitis whereas suffering from localized peritonitis was protective for their development (OR:0.308;95% CI:0.152-0.624;P = 0.001). Multivariate analysis showed that predictors for in-hospital mortality were age (OR:1.028;95% CI:1.011-1.045;P = 0.001), arterial lactate (OR:1.088;95% CI:1.043-1.136; p < 0.001) and APACHE on admission (OR:1.058;95% CI:1.017-1.101;P = 0.005) and the need for Renal Replacement Therapy (OR:1.728;95% CI:1.179-2.533;P = 0.005).
Conclusions
Complicated peritonitis remains a cause of higher mortality in ICU, with urgent surgery, Total Parenteral Nutrition needs and primary infection site of stomach-duodenum as the main factors associated with tertiary peritonitis. Worst APACHE II, higher arterial lactate, older age and Renal Replacement Therapy needs were predictors of in-hospital mortality in those patients.
Published: 1 October 2015
References1. Riche FC, Dray X, Laisne MJ, et al: http://www.ncbi.nlm.nih.gov/pubmed/19552799?dopt=Abstract
Web End =Factors associated with septic shock http://www.ncbi.nlm.nih.gov/pubmed/19552799?dopt=Abstract
Web End =and mortality in generalized peritonitis: comparison between http://www.ncbi.nlm.nih.gov/pubmed/19552799?dopt=Abstract
Web End =community-acquired and postoperative peritonitis. Crit Care 2009, 13(3): R99.
2. Montravers P, Chalfine A, Gauzit R, et al: http://www.ncbi.nlm.nih.gov/pubmed/15075660?dopt=Abstract
Web End =Clinical and therapeutic features http://www.ncbi.nlm.nih.gov/pubmed/15075660?dopt=Abstract
Web End =of nonpostoperative nosocomial intra-abdominal infections. Ann Surg 2004, 239(3):409-416.
doi:10.1186/2197-425X-3-S1-A114Cite this article as: Balls Noguera et al.: Predictors of in-hospital mortality in critically ill patients with secondary and tertiary peritonitis. Intensive Care Medicine Experimental 2015 3(Suppl 1):A114.
Hospital Universitari de Bellvitge, Intensive Care, LHospitalet de Llobregat, Spain
2015 Balls Noguera et al.; This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0
Web End =http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
The Author(s) 2015
Abstract
Issue Title: ESICM LIVES 2015
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer